FDA Panel to Review Moderna’s Flu Vaccine for Older Adults
The U.S. Food and Drug Administration’s (FDA) independent vaccine advisory panel is set to review and vote on whether the benefits of Moderna’s influenza vaccine, mFlusiva, outweigh its potential risks in older adults. Moderna...